Parkinson's disease (PD): peripheral neuropathy

Evidence-based neurology checklist on parkinson's disease (pd): peripheral neuropathy: Risk factors Severity of PD Levodopa exposure: levodopa-induced neuropathy Vitamin B12 deficiency Hyperhomocysteinaemia PD degeneration Genetic disorders manifesting with PD and PN PD neuropathy types

Risk factors

  • Severity of PD
  • Levodopa exposure: levodopa-induced neuropathy
  • Vitamin B12 deficiency
  • Hyperhomocysteinaemia
  • PD degeneration

Genetic disorders manifesting with PD and PN

PD neuropathy types

References

  1. Merola A, Rosso M, Romagnolo A, et al. Peripheral neuropathy as marker of severe Parkinson's disease phenotype. Mov Disord 2017; 32:1256-1258.
  2. Ceravolo R, Cossu G, Bandettini di Poggio M, et al. Neuropathy and levodopa in Parkinson's disease: evidence from a multicenter study. Mov Disord 2013; 28:1391-1397.
  3. Romagnolo A, Merola A, Artusi CA, Rizzone MG, Zibetti M, Lopiano L. Levodopa-induced neuropathy: a systematic review. Mov Disord Clin Pract 2018; 6:96-103.
  4. Rajabally YA, Martey J. Neuropathy in Parkinson disease: prevalence and determinants. Neurology 2011; 77:1947-1950.
  5. Zis P, Grünewald RA, Chaudhuri RK, Hadjivassiliou M. Peripheral neuropathy in idiopathic Parkinson's disease: A systematic review. J Neurol Sci 2017; 378:204-209.
  6. And 8 more. Subscribe to see the full list

Related checklists

Loading...